Liposome-mediated gene transfer into human basal cell carcinoma

Gene Therapy

Volumn 6, Issue 12, 1999, Pages 1929-1935

  Hottiger, M O ^a,d   Dam, T N ^a   Nickoloff, B J ^b   Johnson, T M ^a   Nabel, G J ^a,c  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Antigen presenting cells; Basal cell carcinoma; Cationic liposomes; Gene therapy; Interferon; Lipoplexes

Indexed keywords

ALPHA2 INTERFERON; DNA; LIPOSOME; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BASAL CELL CARCINOMA; CANCER GRAFT; CANCER REGRESSION; CODON; CONTROLLED STUDY; DERMIS; DNA ADDUCT; EPIDERMIS; GENE EXPRESSION; GENE TARGETING; GENE TRANSFER; HUMAN; HUMAN TISSUE; IMMUNE DEFICIENCY; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RECOMBINANT GENE; TISSUE TRANSPLANTATION;

ADULT; AGED; ANIMALS; ANTIGENS, CD1; CARCINOMA, BASAL CELL; FEMALE; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HLA-DR ANTIGENS; HUMANS; IMMUNOHISTOCHEMISTRY; INJECTIONS, INTRALESIONAL; INTERFERON TYPE I, RECOMBINANT; INTERFERON-ALPHA; LIPOSOMES; MALE; MICE; MICE, SCID; MIDDLE AGED; NEOPLASM TRANSPLANTATION; SKIN NEOPLASMS; TREATMENT OUTCOME;

ANIMALIA;

EID: 0033386386     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3301036     Document Type: Article

References (33)

1. Miller DL, Weinstock MA. Nonmelanoma skin cancer in the United States: incidence. J Am Acad Dermatol 1999; 30: 774-778.
2. Buechner SA. Intralesional Interferon alfa-2b in the treatment of basal cell carcinoma: immunohistochemical study on cellular immune reaction leading to tumor regression. J Am Acad Dermatol 1991; 24: 731-734.
3. Cornell RC et al. Intralesional Interferon therapy for basal cell carcinoma. J Am Acad Dermatol 1990; 23: 694-700.
4. Greenway HT et al. Treatment of basal cell carcinoma with intralesional interferon. J Am Acad Dermatol 1986; 15: 437-443.
5. Grob JJ, Collet AM, Munoz MH, Bonerandi JJ. Treatment of large basal-cell carcinomas with intralesional interferon-alpha-2a. Lancet 1988; 1: 878-879.
6. Hunt MJ et al. Regression in basal cell carcinoma: an immunohistochemical analysis. Br J Dermatol 1994; 130: 1-8.
7. Thestrup-Pedersen K, Jacobsen IE, Frentz G. Intralesional interferon-alpha 2b treatment of basal cell carcinoma. Acta Derm Venereol 1990; 70: 512-514.
8. Wickramasinghe L, Hindson TC, Wacks H. Treatment of neoplastic skin lesions with intralesional interferon. J Am Acad Dermatol 1989; 20: 71-74.
9. Chimenti S et al. Use of recombinant interferon alfa-2b in the treatment of basal cell carcinoma. Dermatology 1995; 190: 214-217.
10. Dellon AL, Elfenbein GJ, Orlando JC. Impairment of thymus-derived lymphoid cell function in patients with basal cell carcinoma. J Surg Oncol 1984; 25: 92-97.
11. Murphy GF, Krusinski PA, Myzak LA, Ershler WB. Local immune response in basal cell carcinoma: characterization by transmission electron microscopy and monoclonal anti-T6 antibody. J Am Acad Dermatol 1983; 8: 477-485.
12. Myskowski PL, Safai B, Good RA. Decreased lymphocyte blastogenic responses in patients with multiple basal cell carcinoma. J Am Acad Dermatol 1981; 4: 711-714.
13. Meissner K et al. Quantitative analysis of T6-positive Langerhans cells in human skin cancers. Virchows Arch 1986; 410: 57-63.
14. Knop J. Immunologic effects of interferon. J Invest Dermatol 1990; 95: 72S-74S.
15. Mozzanica N et al. Immunohistological evaluation of basal cell carcinoma immunoinfiltrate during intralesional treatment with alpha 2-interferon. Arch Dermatol Res 1990; 282: 311-317.
16. Buechner SA et al. Regression of basal cell carcinoma by intralesional interferon-alpha treatment is mediated by CD95 (Apo-1/Fas)-CD95 ligand-induced suicide. J Clin Invest 1997; 100: 2691-2696.
17. Nabel GJ et al. Immune response in human melanoma after transfer of an allogeneic class I major histocompatibility complex gene with DNA-liposome complexes. Proc Natl Acad Sci USA 1996; 93: 15388-15393.
18. Nabel GJ et al. Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans. Proc Natl Acad Sci USA 1993; 90: 11307-11311.
19. Nabel GJ et al. Direct gene transfer for treatment of human cancer. In: Liu MA, Hilleman MR, Kurth R (eds). DNA Vaccines: A New Era in Vaccinology. New York Academy of Sciences: New York, 1995, pp 227-231.
20. Stephan DJ et al. A new cationic liposome DNA complex enhances the efficiency of arterial gene transfer in vivo. Hum Gene Ther 1996; 7: 1803-1812.
21. Pawlowski A, Haberman HF. Heterotransplantation of human basal cell carcinomas in 'nude' mice. J Invest Dermatol 1979; 72: 310-313.
22. Grimwood RE et al. Transplantation of human basal cell carcinomas to athymic mice. Cancer 1985; 56: 519-523.
23. l-nu/nu (beige-nude) mice. J Dermatol Surg Oncol 1991; 17: 661-666.
24. Gutterman JU. Cytokine therapeutics: lessons from Interferon alpha. Prof Natl Acad Sci USA 1994; 91: 1198-1205.
25. Pestka S, Langer JA, Zoon KC, Samuel CE. Interferons and their actions. Annu Rev Biochem 1987; 56: 727-777.
26. Pfeffer LM et al. Biological properties of recombinant alpha-interferons: 40th anniversary of the discovery of interferons. Cancer Res 1998; 58: 2489-2499.
27. Horton HM et al. A gene therapy for cancer using i.m. injection of plasmid DNA encoding interferon-a. Proc Natl Acad Sci USA 1999; 96: 1553-1558.
28. San H et al. Safety and short-term toxicity of a novel cationic lipid formulation for human gene therapy. Hum Gene Ther 1993; 4: 781-788.
29. Sambrook J, Fritch EF, Maniatis T. Molecular Cloning: A Laboratory Manual. Cold Spring Laboratory Harbor Press: Cold Spring Harbor, NY, 1989.
30. Leung K, Nabel GJ. HTLV-I transactivator induces interleukin-2 receptor expression through an NF-kB-like factor. Nature 1988; 333: 776-778.
31. Manthorpe M et al. Gene therapy by intramuscular injection of plasmid DNA: studies on firefly luciferase gene expression in mice. Hum Gene Ther 1993; 4: 419-431.
32. Michael G. Nitroblue tetrazolium chloride (NBT). In: Bergmeyer V (ed). Methods of Enzymatic Analysis, 3rd edn. Academic Press: New York, 1983, pp 197-232.
33. Yokota T, Reeves AG, MacLean PD. Intracellular olfactory response of hippocampal neurons in awake, sitting squirrel monkeys. Science 1967; 157: 1072-1074.